News
Youth Using Alternative Tobacco Products Are More Likely to Smoke 1 Year Later
Nonsmoking adolescents who use e-cigarettes, smokeless tobacco or tobacco water pipes are more likely to start smoking conventional cigarettes within a year, according to new research by UC San Francisco. The study analyzed data from a nationally-representative sample of more than 10,000 adolescents
Engineers Hack Cell Biology to Create 3-D Shapes from Living Tissue
In the journey from egg to embryo to mature organism, our bodies stretch and wrinkle and fold like a fabulously intricate piece of origami. Now UC San Francisco bioengineers have shown that many of the complex folded shapes that form mammalian body plans and internal tissue structures can be re
DNA Annotations Predict Patient Outcomes in Childhood Leukemia
UC San Francisco physician-scientists have developed a test that can predict how patients with juvenile myelomonocytic leukemia (JMML) will respond to treatment, and may also be able to identify patients who are likely to recover spontaneously with little to no treatment. The researchers are
2018 Precision Medicine World Conference to Feature UCSF Faculty
For the third consecutive year, UC San Francisco is co-sponsoring the Precision Medicine World Conference (PMWC) in January 2018 to share the latest in the rapidly evolving space. Renamed from the Personalized Medicine World Conference, the annual forum attracts more than 1,000 recognized
Year in Review: 2017
2017 has been a year of collaboration, innovation, and achievement at the Helen Diller Family Comprehensive Cancer. As the year winds down, we take a moment to reflect on some highlights. Our dedicated clinicians, curious researchers, and inspired philanthropists joined forces with patients and
Collaboration Highlights UCSF Cancer Center's Leadership in Precision Medicine for Prostate Cancer
A new collaboration between the UCSF Helen Diller Family Comprehensive Cancer Center (HDFCCC) and the biotechnology company Strata Oncology to provide free genomic testing to men with advanced prostate cancer could help patients nationwide gain access to cutting-edge treatment and lead to new
New Immunotherapy for Deadly Childhood Brain Cancer Targets Novel "Neoantigen"
Children with an extremely deadly form of brain cancer might benefit from a new treatment that aims to direct an immune response against a mutant form of a protein found exclusively on cancer cells, according to a new study led by UC San Francisco researchers. The focus of the study, published